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Research Updates

Research highlights
Homoeopathy as an Add – on for Standard Care
of COVID-19
Title: Efficacy of individualised homeopathy as an adjunct to
standard of care of COVID-19: A randomised, single-blind
and placebo-controlled study
Authors: Debadatta Nayak, Juhi Gupta, Anupriya Chaudhary,
Krishna Gopal Singh, Abhijeet Deshmukh, Deblina Das,
Abhishek Saha, Deepak Kumar, Ashwini Kumar, Ajay Goenka,
S. K. Mishra, Sanjay Gupta, Anil Khurana
Journal: Complementary Therapies in Clinical Practice, DOI:
10.1016/j.ctcp.2022.101602
Summary: A randomised, placebo-controlled and single blind
study was conducted to assess the efficacy of the adjunctive
individualised homoeopathic medicine to standard of care of
COVID-19. Subjects were randomised in two groups, Group 1
receiving standard care (SC) of COVID-19 and individualised
homoeopathic medicine and Group 2 receiving SC and placebo.
Primary outcome measurement was clinical recovery estimated
through change in the total symptom score, whereas secondary
outcome of the study was time taken for fever clearance
and time taken for clinical recovery. Calculation of total
symptom score measured over 10 days indicated statistically
significant difference favouring Group 1 receiving SC along
with individualised homoeopathic medicines. Estimated 2 days
of faster recovery rate was observed in Group 1 with SC
and homoeopathy. Furthermore, faster resolution of fever of
estimated 20 h was observed in SC and homoeopathy group.
The most frequently prescribed medicines were Arsenicum
album, Bryonia alba and Phosphorus. Therefore, this study
concluded a better clinical outcome with respect to early
recovery observed in COVID-19 patients prescribed with
standard of care adjunct with individualised homoeopathic
medicines.
Comments: Homoeopathy as an adjunct treatment integrated
with standard of care for COVID-19 patients may yield better
clinical outcomes. Further double-blinded, controlled studies
could be substantial in validating the results of this study.

Homoeopathy in Primary Care for COVID-19
Title: Homeopathy for COVID-19 in primary care:
A randomised, double-blind and placebo-controlled trial
(COVID-simile study)
Authors: Ubiratan Cardinalli Adler, Maristela Schiabel
Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta,
Amarilys de Toledo Cesar, José Nelson Martins Diniz, Helen
de Freitas Santos, Edson Zangiacomi Martinez

Journal: Journal of Integrative Medicine, DOI: 10.1016/j.
joim.2022.03.003
Summary: A randomised double blind, two armed, parallel
and placebo-controlled clinical trial was conducted from
June 2020 to April 2021 at Sao-Carlos, Brazil with an
objective to investigate the effectiveness and safety of the
homoeopathic medicine Natrum muriaticum LM2, for
mild cases of COVID-19. Primary outcome was assessed
by time taken for recovery from COVID-19 influenza-like
symptoms. Secondary measures included a survival analysis
of the number and severity of COVID-19 symptoms from a
symptom grading scale. The study revealed that there was
no difference in time to recovery between the two groups.
As per the secondary outcomes, 50% reduction in symptom
score was achieved significantly earlier in the homoeopathy
group with basal symptom score more than or equal to 5.
Furthermore, observations such as reduced hospitalisation rates
in homoeopathy group (2.4%) against placebo group (6.8%)
and fewer adverse events reported in homoeopathy group
(three cases) against placebo group (six cases) were observed.
Comments: Although there were no statistically significant
changes observed in the time taken for recovery in both the
groups, Natrum muriaticum LM2 proved to be safe and
effective in managing COVID-19 cases. Further study on larger
sample size is required.

Vitiligo – Individualised Homoeopathic Medicine
and Psoralea Corylifolia Mother Tincture as an
External Application
Title: Add-on Psoralea corylifolia mother tincture external
application to individualised homeopathic medicines in
treatment of vitiligo: Open, randomised, pragmatic and pilot
trial
Authors: Anaitulah Ahmad Mir, Ghulam Nabi Wani,
Ramkripal Prajapati, Nitin Saklani, Avaranjika Karuppusamy,
Pankaj Kanti Jha, Abhijit Chattopadhyay, Chintamani Nayak,
Swapan Paul, S. K. Swaif Ali, Munmun Koley, Subhranil Saha
Journal: Advances in Integrative Medicine, DOI: 10.1016/j.
aimed.2021.03.003
Summary: An open, randomised, three parallel armed,
pragmatic and pilot trial was conducted on 60 vitiligo patients,
wherein first arm received individualised homoeopathic
medicine, second arm received Psoralea corylifolia (PC)
mother tincture as an external application and third arm
received both homoeopathic individualised medicine and
PC mother tincture for external application. Outcome
was measured through vitiligo quality of life (VitiQoL),
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vitiligo area scoring index and dermatological life quality
index, which will be assessed intra-group and inter-group
at baseline, 3rd month and 6th month. All three outcomes
revealed statistically significant intra-group changes over 3 and
6 months. Statistically significant differences were observed
in inter-group analysis only in VitiQoL score in the favour of
second and third group that is, PC mother tincture for external
application and individualised homoeopathic medicine along
with PC mother tincture for external application, respectively.
All three regimens appeared equally effective and safe.
Comments: This study, even though a pilot, indicates a
positive effect of both PC mother tincture as an external
application alone, when combined as an individualised
homoeopathic medicine, along with PC mother tincture for
external application. This study indeed warrants for further
study on larger sample population.

Impact of Carcinoisinum on Adenocarcinoma
Cells of Mammae
Title: Phenotypic changes in mammary adenocarcinoma (4T1)
cells in vitro after treatment with Carcinosinum
Authors: Thaís Cristina da Silva, William Alves Dos Santos,
Sandra A. G. Pinto, Paulo Ricardo Dell’Armelina Rocha,
Elizabeth Cristina Perez Hurtado, Leoni Villano Bonamin
Journal: Homoeopathy, DOI: 10.1055/s-0041-1740967
Summary: This in vitro model study aims to identify possible
phenotypic changes brought by Carcinosinum in different
homoeopathic potencies (12CH; 30CH and 200CH), including
viability using 4T1 cells. The final dilutions were inserted into
the culture medium in a volume equal to 10%, at the time of
cell seeding in comparison to diluted and succussed sterile
pure water as a control. All treated cells were cultured in 25 ml
flasks, with cell density of 25 × 105 cells/ml. After 24 h, cells
were analysed. Carcinosinum 30CH presented the highest
apoptotic index and reduction of MMP-9-pro expression;
Carcinosinum 200CH produced the highest positivity for
HER-2 and no specific effect was seen after the treatment
with Carcinosinum 12CH. In comparison the two treatments,
no significant changes in cytokine expression were observed.
Therefore, this study concludes that Carcinosinum 30CH and
200CH can change phenotypic features important to tumour
development in vitro.
Comments: Homoeopathic nosode Carcinosinum in 30CH
and 200CH potency has a potential to bring about phenotypic
changes of 4T1 tumour cells in vitro model.

Hypericum Perforatum: Post-operative Pain
Killer
Title: Hypericum perforatum to improve post-operative pain
outcome after monosegmental spinal sequestrectomy: Results
of a randomised, double-blind and placebo-controlled trial
196

Authors: Christa K. Raak, Wolfram Scharbrodt, Bettina
Berger, Arndt Büssing, Anna Schönenberg-Tu, David D.
Martin, Sibylle Robens, Thomas Ostermann
Journal: Journal of Integrative and Complementary Medicine,
DOI: 10.1089/jicm.2021.0389
Summary: This randomised double blind, monocentric and
placebo-controlled clinical trial tested whether homoeopathic
medicine Hypericum perforatum was effective in reduction
of radicular post-operative pain experienced in patients
undergoing lumbar spine surgery. Intervention group received
Hypericum perforatum C200 whereas control group was
prescribed with placebo; both groups were on opioids pain
killer medications as per their individual requirements.
Primary outcome measurement was reduction of pain on visual
analogue scale, secondary outcome measure was reduction of
inpatient post-operative analgesic medication and change in
sensory and affective pain. In between the two-study arms,
there was no significant difference in pain perception at
baseline and day 3. On comparison, there was no significant
difference between the groups in the analgesic pain killer
medication consumption; however, a statistical trend and a
moderate effect in the decrease of pain medication consumption
in favour of the Hypericum group were observed.
Comments: This clinical trial although reveals no significant
difference in between the experimental and placebo group. But
a statistical trend towards relative reduction in consumption
of analgesics in Hypericum perforatum arm, shows a good
scope of Hypericum perforatum in reducing pain due to nerve
damage.

Biasedness in Homoeopathic Trials
Title: Assessing the magnitude of reporting bias in trials of
homeopathy: A cross-sectional study and meta-analysis
Authors: Gerald Gartlehner, Robert Emprechtinger, Marlene
Hackl, Franziska L. Jutz, Jacob E. Gartlehner, Julian N.
Nonninger, Irma Klerings, Andreea Iulia Dobrescu
Journal: BMJ Evidence-based Medicine, DOI: 10.1136/
bmjebm-2021-111846
Summary: This critical cross-sectional and meta-analysis
study aimed to assess magnitude of reporting bias in trials
assessing homoeopathic treatments and its impact on evidence
syntheses. Homoeopathic trials were searched from PubMed,
Allied and Complementary Medicine Database, Embase
and Google Scholar up to April 2021. It was observed
that since 2002, almost 38% of registered homoeopathy
trials have remained unpublished and 50% of published
randomised and controlled trials (RCTs) have not been
registered. Furthermore, retrospective registration was more
common than prospective registration. Furthermore, 25% of
primary outcomes were altered or changed compared with
the registry. In comparison to registered RCTs, unregistered
RCTs revealed substantially larger treatment effects that is,
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(SMD = −0.53, 95% CI = [– 0.87]–[– 0.20]) and (SMD = −0.14,
95% CI = [–0.35]–0.07), respectively. Such findings affected
the validity of the body of evidence of homoeopathic literature
and may overestimate the true treatment effect of homoeopathic
remedies.
Comments: The findings of this meta-analysis show that there
exists a possibility of highlighting the positive estimates and
thus raises a doubt about the authenticity of the conclusions
drawn from such homoeopathic RCTs. This calls for further
analysis by experts.

Plantago Major in Pancolitis
Title: Therapeutic effect of Plantago major on active severe
pancolitis: A case report
Authors: Vahid Tafazoli, Erfan Taherifard, Majid Nimrouzi,
Mehdi Pasalar
Journal: Advances in Integrative Medicine, DOI:10.1016/j.
aimed.2021.03.001
Summary: Ulcerative colitis is a highly prevalent disease
globally that presents with significant symptoms including
bloody defecation and inflammation. Herbal medicines prove to
be a promising therapy without resulting in any complications
like colon perforation. The objective of this case report was to
provide data from an alternative approach for the treatment of
pancolitis using a traditional herbal medicine. A 35-year-old
man with chronic pancolitis received Plantago major (5 g in
250 ml hot water) decoction, a traditional Persian medicine
formula, twice daily. Few days from commencing treatment,
patient showed improvement of symptoms. Improvement
was clinically observed after 2 years of follow-up in areas
such as clinical examination, patients’ history, colonoscopy,
pathology test and myoclonic score. The findings of this study
depict potentially positive benefits of Plantago major for the
management for pancolitis.
Comments: This case shows the effect of alternative approach
with herbal medicines like Plantago major in the treatment of
pancolitis. The role of Plantago major can be studied further
in pancolitis.

Apocynum cannabinum in Elephantiasis Nostras
Verrucosa
Title: An integrative therapeutic approach to elephantiasis
nostras verrucosa: A case report
Authors: Lawrence Chukwudi Nwabudike, Olimpia Buzia,
Alina Mihaela Elisei, Alin Laurentiu Tatu

Journal: Experimental and Therapeutic Medicine, DOI:
10.3892/etm.2022.11218
Summary: Elephantiasis nostras is a chronic disorder which is
difficult to treat. It is a characterised by marked lymphedema,
associated with hyperkeratosis, ulceration, deep skin folds and
a cobblestone appearance of the skin. This report consists of a
case of 72-years-old female with renal insufficiency presented
with leg enlargement of 3–4 years duration which affected
her daily routine. Examination showed massive lower limb
enlargement with typical cobblestone appearance. She was
treated with increased furosemide from 80 to 120 mg daily
and homoeopathic medicine Apocynum cannabinum, CH30
potency, t.d.s. The patient remitted over 18 months, with limb
diameters dropping from 68/46 cm (right mid-calf/ankle) and
67/43 cm (left mid-calf/ankle) to 46/35 cm (right mid-calf/
ankle) and 48/36 cm (left mid-calf/ankle) at 18 months, with
improvement of skin appearance. In this case, furosemide
combined with homoeopathic Apocynum cannabinum has
proved valuable and may be used for similar cases.
Comments: This case report provides us with an evidence in
the support of homoeopathy as an adjunct medicine in chronic
cases like Elephantiasis nostras, which respond poorly to
available treatment.
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